This masterclass will present the state-of-the-art in immune regulatory therapies, with a particular focus on cellular therapies which are undergoing clinical evaluation.
“This Masterclass has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”Attendance to the live Masterclass and the completion of the post-event survey are mandatory to receive the certificate and CME credits.
“Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
“Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”
Welcome and introduction by the Chairs
Presentation: Are all cell therapies created equal? Edward K. Geissler, Germany
Live Q&A with Edward K. Geissler, Germany
Presentation: The promise of IL-2 therapy in transplantation, Alberto Sanchez Fueyo, UK
Live Q&A with Alberto Sanchez Fueyo, UK
Interactive panel discussion with audience participation led by the Chairs
Masterclass closing remarks